Why do we need to sell? So these great products can get to those who need them sooner rather than later. Neuren at the moment has little expertise in getting a drug through Phase 3, and the ASX is no place for a company with this potential to be. How many other great ASX listed success stories have there been in the biotech field? Oh, that's right. None. And for good reason. Sell and grow, or hold and wither. Take your pick.
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-8815
-
- There are more pages in this discussion • 2,449 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.60 |
Change
-0.340(2.13%) |
Mkt cap ! $1.993B |
Open | High | Low | Value | Volume |
$16.25 | $16.32 | $15.55 | $9.440M | 595.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 3197 | $15.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.68 | 1852 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 351 | 16.750 |
2 | 2317 | 16.380 |
1 | 95 | 16.100 |
1 | 2309 | 16.000 |
1 | 22 | 15.880 |
Price($) | Vol. | No. |
---|---|---|
15.520 | 234 | 2 |
15.550 | 674 | 2 |
15.700 | 30 | 1 |
15.730 | 1000 | 1 |
15.800 | 349 | 1 |
Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online